BRNS: the balance sheet

MyFinsight

For the year ending 2025-12-31, BRNS has $98,169K in assets. $23,877K in debts. $70,456K in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	70,456
Restricted cash	1,396
Research and development incentives receivable	1,108
Prepaid expenses and other current assets	4,830
Total current assets	77,790
Property and equipment, net	3,523
Intangible assets, net	14,288
Right of use assets, net	1,638
Other assets	930
Total assets	98,169

Accounts payable	350
Accrued expenses and other current liabilities	6,249
Deferred income	1,396
Operating lease liability - current	2,023
Total current liabilities	10,018
Operating lease liability - non-current	9,258
Contingent consideration	2,871
Other non-current liabilities	1,476
Deferred tax liability, net	254
Total liabilities	23,877
Ordinary shares, 0.000025 nominal value 40,848,893 shares authorized, issued and outstanding (december31, 2024 authorized, issued and outstanding 40,234,663)	1
Deferred a shares, 1 nominal value 63,443 shares authorized, issued and outstanding (december31, 2024 authorized, issued and outstanding 63,443)	86
Additional paid-in capital	393,944
Accumulated deficit	-304,092
Accumulated other comprehensive loss foreign currency translation adjustments	-15,731
Total stockholders equity attributable to barinthus biotherapeutics plc shareholders	74,208
Noncontrolling interest	84
Total stockholders equity	74,292
Total liabilities and stockholders equity	98,169

Unit: Thousand (K) dollars (except for numbers of shares and EPS).